Suchergebnisse - %22Immunosuppressive Agents%22

PubPharm (8)

1

New Applications for Traditional Drugs in Inflammatory Bowel Disease : What Do Cochrane Reviews Tell Us?

enthalten in: Inflammatory bowel diseases | 2015

von Chande, N. | Marshall, J. | Seow, C. | +4

2

The cytotoxic effects of certolizumab pegol and golimumab mediated by transmembrane tumor necrosis factor α

enthalten in: Inflammatory bowel diseases | 2013

von Ueda, N. | Tsukamoto, H. | Mitoma, H. | +8

3

Collagenous colitis-like condition in immunosuppressed infant baboons

enthalten in: Inflammatory bowel diseases | 2012

von Dons, E. | Echeverri, G. | Rigatti, L. | +6

4

Long-term therapy with sargramostim in a patient with Crohn's disease

enthalten in: Inflammatory bowel diseases | 2011

von Wong, A. | Lee, S.

5

Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease

enthalten in: Inflammatory bowel diseases | 2009

von Mantzaris, G. | Christidou, A. | Sfakianakis, M. | +4

6

Oral budesonide for the therapy of post-liver transplant de novo inflammatory bowel disease : a case series and systematic review of the literature

enthalten in: Inflammatory bowel diseases | 2008

von Barritt, A. | Zacks, S. | Rubinas, T. | +1

7

Conventional treatment of Crohn's disease : objectives and outcomes

enthalten in: Inflammatory bowel diseases | 2001

von Rutgeerts, P.

8

Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease

enthalten in: Inflammatory bowel diseases | 2001

von Lichtenstein, G.

1
[1]